EUDA Health Holdings Ltd (EUDA) EBITDA Margin (2022 - 2023)
EUDA Health Holdings (EUDA) posted quarterly EBITDA Margin of 708.67% for Q2 2023, down 63750.0% year-over-year from N/an in Q2 2022, and down 508.99% quarter-over-quarter from 116.37% in Q1 2023.
EUDA Health Holdings Ltd (EUDA) EBITDA Margin (2022 - 2023) Analysis & Trends
EUDA Health Holdings (EUDA) has reported EBITDA Margin for 2 consecutive years, with 708.67% the latest figure, recorded in Q2 2023.
- In Q2 2023, EBITDA Margin fell 63750.0% year-over-year to 708.67%; the TTM figure through Jun 2023 stood at 209.92% (changed N/A YoY), while the FY2025 annual figure was 36.33%, up 39586.0% from the prior year.
- EBITDA Margin declined to 708.67% in Q2 2023 per EUDA's latest filing, from 116.37% in the prior quarter.
- Across five years, EBITDA Margin topped out at 2.82% in Q1 2022 and bottomed at 708.67% in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -708.67% |
| Mar 31, 2023 | -116.37% |
| Jun 30, 2022 | -71.17% |
| Mar 31, 2022 | 2.82% |